Double Standard on the Treatment of Chronic Hepatitis B Liver Clinical.docVIP

Double Standard on the Treatment of Chronic Hepatitis B Liver Clinical.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Double Standard on the Treatment of Chronic Hepatitis B Liver Clinical

 PAGE \* MERGEFORMAT 6 Double Standard on the Treatment of Chronic Hepatitis B Liver Clinical [Keywords:] Double Standard Qinggan particles with chronic hepatitis B I double tiger Qinggan Immunotoxin Treatment of TCM for the excessive heat, phlegm in the resistance, blood stasis in patients with chronic hepatitis B card, and the control group, compared to observe the symptoms and signs, liver function and liver fibrosis changes in serum markers to help its clinical evaluation. 1 Materials and Methods 1.1 Case Selection Select July 2005 -2006 and our hospital in December TCM clinic for the Immunotoxin excessive heat, phlegm in the resistance, blood stasis syndrome in 100 patients with chronic hepatitis B patients. Based on 2000 Sixth National Conference infectious parasitic diseases revised diagnostic criteria [1], 57 patients with moderate chronic hepatitis, 30 patients with severe chronic hepatitis, liver cirrhosis in 13 cases. The patients were randomly divided into 2 groups: treatment group of 50 patients, 38 male and female 12 patients, age (36.6 + -10.4 years) in the control group of 50 patients, 37 males and 13 females, age (36.2 + -11.4 years) .2 group in age, gender, no significant differences between the disease and treatment before June and did not conduct anti-virus, anti-fibrosis treatment. all except for HCV, HDV, HAV, HEV and other hepatitis virus superinfection and decompensated cirrhosis. 1.2 Treatment The control group of 50 patients, oral silymarin tablets (Shandong Conway Pharmaceutical Limited, registration number: ZZ-3604-Lu Yao Zhunzi [2001] No. 128 201), 1 2, 3 times a day course of treatment for 12 weeks, the treatment group of 50 patients, oral double tiger Qinggan particles (CES Beijing Pharmaceutical Co., Ltd., batch number , 2 bags each time, 2 times a day, duration of treatment was 12 weeks. 1.3 OUTCOME MEASURES 2 groups were observed clinical symptoms and signs, respectively, before treatment, c

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档